Ted William Karkus - 09 Sep 2025 Form 4 Insider Report for ProPhase Labs, Inc. (PRPH)

Reporting relationship: CEO & CHAIRMAN, Director
Issuer ticker: PRPH
Reported as of: 09 Sep 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Sep 2025, 16:05:22 UTC
Prior SEC filing: 19 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Ted Karkus

Key filing fact

Ted William Karkus filed Form 4 for ProPhase Labs, Inc. (PRPH) on 11 Sep 2025.

Key facts

This page summarizes Ted William Karkus's Form 4 filing for ProPhase Labs, Inc. (PRPH).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 11 Sep 2025, 16:05.

Change

Previous filing in this sequence was filed on 19 Mar 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001457896 Primary reporting owner

Karkus Ted William

Relationship: CEO & CHAIRMAN, Director
Address: 626 RXR PLAZA, 6TH FLOOR, UNIONDALE,
Signature: /s/ Ted Karkus
Signature date: 09 Sep 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PRPH transaction Derivative

warrants

Award

Transaction value: $0
Shares: +500,000
Change %
Price: $0.000000
Shares after: 500,000
Date: 09 Sep 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 500,000
Exercise price: $0.6000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Warrants issued upon increase in authorized shares being approved by shareholders. The Reporting Person loaned PRPH funds, with a contingency that a warrant to purchase 500,000 shares of the Issuer's common stock at an exercise price of $0.60 per share would be issued if and only if the company's shareholders approved an amendment to the Certificate of Incorporation increasing the authorized shares of common stock from 50,000,000 to 1,000,000,000. Shareholders approved the increase in the authorized shares on September 9, 2025. The Warrant is described in the Issuer's Current Report on Form 8-K/A filed June 26, 2025 (Item 1.01), which states the Warrant has a five-year term. The expiration date shown (09/09/2030) is a five-year term from the issuance date. The Warrant was issued as consideration in connection with a related-party loan agreement between the Issuer and the Reporting Person dated June 22, 2025. See Form 8-K/A filed June 26, 2025 for additional details.